MYLAN INC

HEALTHY LIVING
Mylan Settles With Feds For $465 Million Over EpiPen Controversy
By Nate Raymond, Reuters
The company was accused of overcharging the government for EpiPens.
HEALTHY LIVING
Drugmaker Mylan Gets Tax Boost From Refined Coal
By Michael Erman, Reuters
Refined coal has quietly generated hundreds of millions of dollars of tax credits for the company over the last six years.
BUSINESS
Mylan May Have Overcharged U.S. For EpiPen By $1.27 Billion
By Michael Erman, Reuters
The amount is nearly three times a proposed settlement that the company announced in October.
HEALTHY LIVING
FDA Warns Mylan Over Quality Concerns At India Facility
By Natalie Grover, Reuters
Violations included a failure to “thoroughly investigate” unexplained discrepancies in drug batches and “missing, deleted, and lost data."
HEALTHY LIVING
Mylan Hit With New Class Action Lawsuit Over EpiPen Pricing
By Brendan Pierson, Reuters
The company came under fire last year after prices for its allergy devices shot up.
HEALTHY LIVING
Mylan EpiPen Device Recall To Expand In U.S. And Abroad
By Akankshita Mukhopadhyay, Reuters
Last week, around 81,000 EpiPen devices were recalled in foreign countries.
HEALTHY LIVING
Mylan Recalls 81,000 EpiPens Outside U.S. After Reports Of Failure
The life-saving allergy shot failed to work in emergencies.
HEALTHY LIVING
Trump's Pick To Lead Health Agency Calls EpiPen Issue 'Disturbing'
By Susan Cornwell, Reuters
Mylan came under fire last year for misclassifying its lifesaving allergy pen as a generic drug.
HEALTHY LIVING
Mylan Launches EpiPen Generic At $300 Per Two-Pack
The discount comes after a government investigation into EpiPen's 2008 price hike.
POST 50
Female Fortune 500 CEOs At Record High
With Mylan Pharmaceuticals' announcement today that Heather Bresch -- company president and daughter of West Virginia Senator